Market valued at $1.68B in 2024, projected to reach $4.58B by 2033 at 13.4% CAGR, driven by chronic wound prevalence ...
Q2 2026 Earnings Call February 15, 2026 5:00 PM ESTCompany ParticipantsNeil Salmon - MD, CEO & DirectorBrian Montgomery - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results